effects [qlco]
weeks [tmco]
treatment [ftcn]
Proton pump inhibitor [phsu]
Insulin [aapp, horm, phsu]
secretion [biof]
glucose metabolism [moft]
Marker [clna]
CARDIOVASCULAR [bdsy]
Patients [podg]
Type 2 Diabetes [dsyn]
DOUBLE BLIND [resa]
prospective [resa]
placebo controlled study [inpr, resa]
Suggest [idcn]
Proton pump inhibitor [phsu]
treatment [ftcn]
insulin secretion [celf]
glucose metabolism [moft]
Type 2 Diabetes [dsyn]
Double-Blind Study [resa]
prospective [resa]
placebo-controlled [resa]
FACTORIAL [resa]
Examined [fndg]
Esomeprazole [orch, phsu]
insulin secretion [celf]
HbA [aapp, bacs]
cardiovascular risk factor [dsyn]
Type 2 Diabetes [dsyn]
Patients [podg]
Type 2 Diabetes [dsyn]
dietary control [topp]
Oral [spco]
Glucose [bacs, carb, phsu]
lowering [spco]
treatment [ftcn]
Receive [qlco]
ADD [mobd]
Esomeprazole 40 MG [clnd]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
weeks [tmco]
Randomization [resa]
carried [acty]
Out [spco]
Inclusion [qlco]
Computer [mnob]
Generated [acty]
RANDOM [resa]
List [cnce]
Allocation [acty]
Sequence [nusq]
Concealed [qlco]
Seal [mamm]
envelope [celc]
Researcher [prog]
participants [popg]
Study [mnob]
Steno [mamm]
Diabetes [dsyn]
Center [spco]
Denmark [geoa]
Primary [qlco]
AUC [qnco]
insulin levels [lbpr]
Meal [dora]
Test [lbpr]
secondary [neop]
Levels [qlco]
HbA [aapp, bacs]
Markers, Biochemical [qlco]
CARDIOVASCULAR [bdsy]
Including [ftcn]
Lipids [lipd]
Coagulation Factors [aapp, bacs, phsu]
Inflammation [patf]
Marker [clna]
Marker [clna]
Endothelial [tisu]
function [phsf]
H+ [elii]
Ambulatory [ftcn]
measurements [ftcn]
participants [popg]
Esomeprazole [orch, phsu]
treated [topp]
Group [idcn]
AUC [qnco]
Insulin [aapp, horm, phsu]
Before [tmco]
treatment [ftcn]
32-P [elii, irda, phsu]
pmol/L [qnco]
placebo [topp]
Group [idcn]
AUC [qnco]
Insulin [aapp, horm, phsu]
Decreased [qnco]
pmol/L [qnco]
pmol/L [qnco]
P NOS [aapp, imft]
Esomeprazole [orch, phsu]
treatment [ftcn]
N NOS [aapp, imft]
AUC [qnco]
Gastrin [aapp, horm]
HbA [aapp, bacs]
Increased [qnco]
MMOLE [qnco]
Mole [neop]
MMOLE [qnco]
Mole [neop]
Esomeprazole [orch, phsu]
treated [topp]
Group [idcn]
MMOLE [qnco]
Mole [neop]
MMOLE [qnco]
Mole [neop]
placebo [topp]
Group [idcn]
N NOS [aapp, imft]
P NOS [aapp, imft]
Group [idcn]
Marker [clna]
CARDIOVASCULAR [bdsy]
P NOS [aapp, imft]
Monitoring [hlca]
H+ [elii]
Ambulatory [ftcn]
Decrease [qlco]
Daytime [tmco]
systolic bp [clna]
Daytime [tmco]
diastolic bp [clna]
H+ [elii]
diastolic bp [clna]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Seen [qlco]
Patients [podg]
treated [topp]
Esomeprazole [orch, phsu]
treatment [ftcn]
Esomeprazole [orch, phsu]
weeks [tmco]
insulin secretion [celf]
glycemia [carb]
Cardiovascular disease [dsyn]
Biomarkers [clna]
Patients [podg]
Type 2 Diabetes [dsyn]
GOV [gngm]
Study [mnob]
funded [qnco]
novo nordisk [hcro]
Christian [idcn]
